Related Experiment Video
Updated: May 5, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Back to the future: the 'old-fashioned' way to new medications for neurodegeneration
1Harvard Center for Neurodegeneration and Repair and the Department of Neurology, Harvard Medical School, Center for Neurologic Diseases, Brigham and Women's Hospital, 65 Landsdowne St., Cambridge, Massachusetts 02139, USA. plansbury@rics.bwh.harvard.edu
Abstract:
Despite the increasing prevalence of Alzheimer's disease, Parkinson's disease and less common neurodegenerative diseases-and despite the large amount of primary research that has been carried out into the causes and pathogenic features of these conditions-progress toward effective treatments has been remarkably slow. Why is this, and what can be done to accelerate it? There are a number of obstacles to effective drug discovery for neurodegeneration, but by considering these problems it is possible to identify lessons for the future.
Insights
Effective treatments for neurodegenerative diseases like Alzheimer's and Parkinson's are slow to develop. Identifying obstacles in drug discovery for neurodegeneration can accelerate future therapeutic progress.
Area of Science:
- Neuroscience
- Pharmacology
- Drug Discovery
Background:
- Neurodegenerative diseases, including Alzheimer's and Parkinson's, are increasingly prevalent.
- Significant research exists on the causes and pathology of these conditions.
Purpose of the Study:
- To investigate the reasons behind the slow progress in developing effective treatments for neurodegenerative diseases.
- To identify obstacles hindering drug discovery in neurodegeneration.
- To derive lessons for accelerating future therapeutic development.
Main Methods:
- Analysis of existing research on neurodegenerative diseases.
- Identification and examination of challenges in neurodegenerative drug discovery.
Main Results:
- Progress toward effective treatments for neurodegenerative diseases has been notably slow.
- Several key obstacles impede successful drug discovery in this field.
Conclusions:
- Understanding the specific challenges in neurodegenerative drug discovery is crucial.
- Addressing these obstacles can pave the way for accelerated development of novel therapies.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Therapy
Antianxiety Medications

